Cargando...
HGG-26. DRAMATIC RESPONSE IN A CHILD TREATED FOR GLIOBLASTOMA WITH IMMUNE CHECK POINT INHIBITOR NIVOLUMAB
INTRODUCTION: Glioblastoma is not curable with current available therapies. Evidence has shown that tumours with a high mutational load can respond to immune check point inhibitors. PATIENT AND METHODS: We present the case of an 11 year old boy treated for intracranial malignant nerve sheet tumour a...
Gardado en:
| Publicado en: | Neuro Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6012745/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.298 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|